Literature DB >> 19086451

[Activation of human neutrophils by hemin].

Katsuyasu Saigo1, Makoto Hashimoto, Yukie Jyokei, Mariko Takenokuchi, Takeshi Sugimoto, Kimiko Kazumura, Hiroshi Tsuchiya, Shion Imoto, Shunichi Kumagai.   

Abstract

Activation of neutrophils by free heme is considered as one of the mechanisms for cellular dysfunction under the conditions of hemorrhage or tissue damage. We studied about the effects of hemin, ferriprotoporphyrin IX, on human neutrophil activation by measurements of adhesion molecule expression and reactive oxygen species (ROS) production. Human neutrophils purified from heparinized blood of healthy volunteers were stimulated with hemin. Surface expression of CD11b and L-selectin were evaluated by flow cytometry, and superoxide production was detected by chemiluminescence. Hemin increased the expression of CD11b and produced superoxide accompanying by increase in intracellular free calcium concentration. Thus, free heme-molecule is suggested to possess the activity to initiate or aggravate tissue injuries. Since neutrophils do not express CD163, scavenger receptor for hemoglobin-haptoglobin complex, the mechanisms by which hemin exerts these effects are still to be studied.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19086451

Source DB:  PubMed          Journal:  Rinsho Byori        ISSN: 0047-1860


  2 in total

1.  Recombinant thrombomodulin does not impair neutrophil functions.

Authors:  Katsuyasu Saigo; Chisako Mori; Shuta Iwamoto; Kohei Shirai; Tomoko Uematsu; Mariko Takenokuchi; Mari Kono; Shion Imoto
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

2.  Morphological and flow-cytometric analysis of haemin-induced human neutrophil activation: implications for transfusion-related acute lung injury.

Authors:  Mari Kono; Katsuyasu Saigo; Yuri Takagi; Sawako Kawauchi; Atsushi Wada; Makoto Hashimoto; Takeshi Sugimoto; Mariko Takenokuchi; Takashi Morikawa; Kunihiro Funakoshi
Journal:  Blood Transfus       Date:  2012-06-28       Impact factor: 3.443

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.